Generic name |
ticagrelor |
---|---|
Strength |
90 mg |
Form | tablet |
Special Authority criteria |
Approval period |
---|---|
To be taken in combination with ASA 75 mg – 150 mg1 daily for patients with acute coronary syndrome (i.e., ST elevation myocardial infarction [STEMI], non-ST elevation myocardial infarction [NSTEMI] or unstable angina with ONE of the following: Failure on optimal clopidogrel and ASA therapy as defined by definite stent thrombosis2 or recurrent STEMI or NSTEMI or UA after revascularization with percutaneous coronary intervention (PCI) OR STEMI, NSTEMI or UA and undergoing revascularization via PCI. Notes:
Definite stent thrombosis must be confirmed by angiography or by pathologic evidence of acute thrombosis. |
Up to 12 months |